Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Signature Biologics, LLC
WARNING LETTER
•Signature Biologics, LLC•December 16, 2021

Signature Biologics, LLC – FDA Warning Letter, Dec 16, 2021

Record Details

The FDA issued a Warning Letter to Signature Biologics, LLC, following a December 2021 inspection, for manufacturing and distributing "Signature Cord™," a human umbilical cord-derived product for allogeneic use. The FDA determined this product is a drug and biological product under the FD&C Act and PHS Act, not solely an HCT/P, because it fails to meet minimal manipulation criteria (21 CFR 1271.10(a)(1)).

Consequently, Signature Cord™ requires an approved Biologics License Application (BLA) or an Investigational New Drug (IND) application, neither of which is in effect. This constitutes violations of the FD&C Act and PHS Act.

The inspection also revealed significant Current Good Manufacturing Practice (CGMP) deviations (21 U.S.C. 351(a)(2)(B) and 21 CFR Parts 210 and 211), affecting over (b)(4) vials manufactured between November 2018 and December 2021. Deficiencies include: 1. Failure to validate aseptic processes for maximum commercial batch sizes (21 CFR 211.113(b)). 2. Inadequate environmental monitoring in aseptic processing areas, including insufficient viable air monitoring and excessively high acceptable microbial limits (21 CFR 211.42(c)(10)(iv)).

Company
Signature Biologics, LLC
Inspection date
December 16, 2021
Product type
Biologics
Office
Division of Biological Products Operations II
People
  • Karlton T. Watson (Program Division Director)
  • Chloe R. Bailey
View Company Profile

ID · 06674d44-47c9-47d3-aca2-ad6bbea17a42

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)21 U.S.C. 355(i)21 CFR 1271.3(d)21 CFR 1271.10(a)21 CFR 1271.1521 CFR 1271.10(a)(1)21 CFR 1271.3(f)(1)21 CFR 211.113(b)21 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.

Other documents for Signature Biologics, LLC
  • 483 - 2021-12-16December 16, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Signature Biologics, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.